Navigation Links
Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop

M.D., The University of Tokushima Graduate School of Health Biosciences * Abstract #311; Poster session: Tuesday 26th June, 4:30 p.m. -- Effect of VELCADE Monotherapy and VELCADE Based Regimens on Bone Metabolism in Patients with Relapsed / Refractory Multiple Myeloma * Lead investigator: Evangelos Terpos, M.D., General Airforce Hospital * Abstract #320; Poster session: Tuesday 26th June, 4:30 p.m. -- Cystatin-C: An Early Marker of Renal Impairment and an Independent Predictive Factor for Survival in Multiple Myeloma. Reduction Post VELCADE Therapy * Lead investigator: Evangelos Terpos, M.D., General Airforce Hospital * Abstract #227; Poster session: Tuesday 26th June, 4:30 p.m. -- VELCADE in Renally Impaired Multiple Myeloma Patients * Lead investigator: Jesus San Miguel, M.D., PhD., Hospital Universitario de Salamanca * Abstract #1114; Poster session: Thursday 28th June, 4:30 p.m.

VELCADE Shows Potential in Additional Diseases and in Combination with Emerging Agents

New data will highlight VELCADE efficacy in amyloidosis, a disease of high unmet need, and in combination with new agents such as HSP90-, AKT- and mTOR-inhibitors. Abstract highlights include:

    -- Treatment of Light Chain (AL) Amyloidosis with the Combination of

       VELCADE and Dexamethasone

         * Lead investigator: Efstathios Kastritis, M.D., Alexandra Hospital,

           University of Athens School of Medicine

         * Abstract #913; Poster session: Thursday 28th June, 4:30 p.m.

    -- VELCADE and Tanespimycin in Multiple Myeloma: Pharmacology, Safety and

       Activity in Relapsed / Refractory Patients

         * Lead investigator: Paul Richardson, M.D., Dana-Farber Cancer

           Institute

         * Abstract #610; Poster session: Thursday 28th June, 4:30 p.m.

    -- A Multicenter Phase I
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... and DURHAM, N.C. , July 2, ... announced its acquisition of assets related to the ion ... ) that had previously been obtained as part of ... acquired all of Pfizer,s rights to the "Icagen" name ... and will provide comprehensive services for ion channel and ...
(Date:7/2/2015)... Research and ... of the "2015 New Frontiers in ... Technologies, Competitive Landscape" report to their ... Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging ... strategic analysis of major business opportunities emerging ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... Health Group, Inc., (EHG), a provider of enhanced connectivity, ... providers in the dental industry, today announced its full ... provide a single-source solution for EDI transactions between the ... Management Software is an intuitive, full-featured program designed to ...
... Sarnova, Inc., the nation,s leading specialty distributor of health ... respiratory markets, announced today that it has acquired Metropolitan ... supplier serving the mid-Atlantic region. Sarnova plans to ... Services brand, which specializes in respiratory and ...
Cached Medicine Technology:EDI Health Group Partners With Orthoease to Incorporate Claims Processing Into Company's Robust Practice Management Software 2EDI Health Group Partners With Orthoease to Incorporate Claims Processing Into Company's Robust Practice Management Software 3Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 2Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 3
(Date:7/2/2015)... ... ... The ZAC Foundation, a national leader in water safety education and drowning prevention, ... water safe with the help of a young polar bear named Zeke. , ... Zeke’s water safety journey. Zeke, who is afraid of the water and refuses ...
(Date:7/2/2015)... PLAINSBORO, N.J. (PRWEB) , ... July 02, 2015 ... ... ACO and Emerging Healthcare Delivery Coalition met for the late June Web-based ... moves forward with new reimbursement schemes and managing high-risk patients through coordinated care. ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... Krishnareddy, M.D., to the orthopedic and spine surgery team at their Anaheim clinic. ... bursitis, and tendonitis. Along with the spine and spine surgery, Dr. Krishnareddy also ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... with care and precision. There is an art and science that goes into ... of successfully reshaping the facial features and lives of more than 2,500 satisfied ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... and wrist pain treatment. Dr. Lev Kalika, founder of New York Dynamic ... international authority on the conservative treatment of back, hip, knee and shoulder pain ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4
... and,health organizations should work together to support ... at the World Conservation,Congress on October 8, ... Wilson International Center for Scholars and the ... combining,population, health, and environment efforts can be ...
... Medical, Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... will participate at the Second,Annual Natixis Bleichroeder Hidden ... Michael Dale, President and CEO of ATS Medical, ... October 13, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ...
... The following was,released by the U.S. ... ceremony for the Alzheimer,s,Awareness 42-cent social awareness ... Rockefeller Neurosciences Institute,s http://www.brni.org new,research ... D. Rockefeller IV, U.S. Postal Service ...
... Ariz., Oct. 9 Gilbert Hospital was,a proud sponsor of ... year at the Encanterra Golf Club. This year, the,event not ... 738,which is also based in Queen Creek., "Any time ... and the,Chamber, it shows our commitment to the area," stated ...
... Scientists have identified some of the elusive downstream molecules that ... familial breast cancer. The research, published by Cell Press in ... also identifies a compound found in grapes and red ... of breast cancer. , About 8% of breast cancer cases ...
... led by Johns Hopkins Children,s Center challenge the longstanding ... believed to fight inflammation and prevent lung disease. The ... benefit and that low cortisol levels are not even ... appeared to increase the risk of dangerous bleeding in ...
Cached Medicine News:Health News:Save Money, Lives, and the Earth by Combining Conservation and Family Planning, Say Experts at World Conservation Congress 2Health News:ATS Medical to Participate at the Natixis Bleichroeder Second Annual Hidden Gems Conference 2Health News:Postal Service to Issue Alzheimer's Awareness Stamp 2Health News:New findings may improve treatment of inherited breast cancer 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 3
RayShield Frame Mounted Overhead Lead Acrylic Barriers are offered in a choice of three sizes: 60 cm x 80 cm ( 24" x 32") wide, 60 cm x 50 cm( 24" x 20") wide. Lead acrylic windows of 0.5 mm and 1.0 ...
Thyroid Collars...
Wrap-Around, Full Protection Apron with BACK SUPPORT...
Shoulder Drop-Off Apron...
Medicine Products: